TY - JOUR AU - Zhang, Shannon PY - 2013 TI - Prof. Yi-Long Wu: Patients on the afatinib arm had a significantly better quality of life according to the data of LUX-Lung 6 JF - Chinese Clinical Oncology; Vol 3, No 4 (December 01, 2014): Chinese Clinical Oncology Y2 - 2013 KW - N2 - Prof. Yilong Wu (Figure 1) is a consultant oncologist, PhD supervisor, Fellow of American College of Surgeons, Vice President of GGH and Guangdong Academy of Medical Sciences as well as Director of Cancer Center, Director of Guangdong Lung Cancer Institute, member of the Council of the Chinese Anti-cancer Association, Chairman of the Chinese Society of Clinical Oncology (CSCO), Chairman of the Chinese Society of Lung Cancer (CSLC), President of Guangdong Association of Clinical Trial. UR - https://cco.amegroups.org/article/view/3129